Eagle Asset Management Inc
- SEC CIK
- 0000790502
- Latest filing
- Nov 12, 2024
HBIO holding history
Harvard Bioscience Inc in every 13F filed by Eagle Asset Management Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
HBIO overviewAll 13F holders of HBIOFull Q3 2024 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −13,835−100.0% | Sold out | Holders |
| Q4 2023 | 13,835 | $74.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 13,835 | $59.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 13,835 | $76.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 13,835 | $58.0K | <0.1% | +13,835 | New | Holders |